Showing results (211-220 of 2,355) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|February 1, 1991
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trialE Martignoni, C Pacchetti, L Sibilla, et al.
Clinical Neuropharmacology|August 1, 1991
Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR)I R Wilding, J G Hardy, S S Davis, et al.
Clinical Neuropharmacology|August 1, 1991
Clinical effects of daily methamphetamine administrationM Perez-Reyes, W R White, S A McDonald, et al.
Clinical Neuropharmacology|July 22, 2009
Milnacipran: beyond a role of antidepressantChi-Un Pae, David M Marks, Manan Shah, et al.
Clinical Neuropharmacology|July 22, 2009
Association of adverse drug effects with subjective well-being in patients with schizophrenia receiving stable doses of risperidoneJong-Hoon Kim, Min-Jung Kim
Clinical Neuropharmacology|July 22, 2009
Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing?Oliver Lange, Hans Bigalke, Reinhard Dengler, et al.
Clinical Neuropharmacology|July 22, 2009
Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosingMohd Makmor-Bakry, Graeme J Sills, Nikolas Hitiris, et al.
Clinical Neuropharmacology|December 4, 2008
Electrophysiological study in 2 children with transient hypohidrosis induced by topiramateLucia Margari, Patrizia Ventura, Maura Buttiglione, et al.
Clinical Neuropharmacology|October 27, 2009
Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic strokeNai-Wen Tsai, Wen-Neng Chang, Chen-Fu Shaw, et al.
Clinical Neuropharmacology|February 13, 2010
Iatrogenic botulism after botulinum toxin type A injectionsArzu Coban, Zeliha Matur, Hasmet A Hanagasi, et al.
Pageof 236